|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Groome PA, O'Sullivan B, Irish JC,
Rothwell DM, Schulze K, Warde PR, Schneider KM, Mackenzie RG,
Hodson DI, Hammond JA, et al: Management and outcome differences in
supraglottic cancer between Ontario, Canada, and the surveillance,
epidemiology, and end results areas of the United States. J Clin
Oncol. 21:496–505. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marur S and Forastiere AA: Forastiere,
Head and neck squamous cell carcinoma: Update on epidemiology,
diagnosis, and treatment. Mayo Clin Proc. 91:386–96. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Awan HM, Shah A, Rashid F and Shan G:
Primate-specific long non-coding RNAs and microRNAs. Genomics
Proteomics Bioinformatics. 15:187–195. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–46. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Parasramka MA, Maji S, Matsuda A, Yan IK
and Patel T: Long non-coding RNAs novel targets for therapy in
hepatocellular carcinoma. Pharmacol Ther. 161:67–78. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao D, Ding Q, Yu W, Gao M and Wang Y:
Long noncoding RNA SPRY4-IT1 promotes malignant development of
colorectal cancer by targeting epithelial-mesenchymal transition.
Onco Targets Ther. 9:5417–5425. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cui WN, Meng WX, Zhao L, Cao H, Chi W and
Wang BS: TGF-β-induced Long non-coding RNA MIR155HG promotes the
progression and EMT of laryngeal squamous cell carcinoma by
regulating themiR-155-5p SOX10 axis. Int J Oncol. 54:2005–2018.
2019.PubMed/NCBI
|
|
12
|
Song X, Zhang X, Wang X, Chen L, Jiang L,
Zheng A, Zhang M, Zhao L and Wei M: LncRNA SPRY4-IT1 regulates
breast cancer cell stemness through competitively binding
miR-6882-3p with TCF7L2. J Cell Mol Med. 24:772–784. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen H, Li ML and Huang P: LncRNA SNHG16
promotes hepatocellular carcinoma proliferation, migration and
invasion by regulating miR-186 expression. J Cancer. 10:3571–3581.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Huang YQ, Song W, Li Y, Wang H,
Wang WJ and Huang M: Comprehensive analysis of the
lncRNA-associated competing endogenous RNA network in breast
cancer. Oncol Rep. 42:2572–2582. 2019.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y,
Chen W, Liu F, Sun W, Li XF, et al: Exosome-transmitted lncARSR
promotes sunitinib resistance in renal cancer by acting as a
competing endogenous RNA. Cancer Cell. 29:653–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo W, Liang X, Liu L, Guo Y, Shen S,
Liang J and Dong Z: MiR-6872 host gene SEMA3B and its antisense
lncRNA SEMA3B-AS1 function synergistically to suppress gastric
cardia adenocarcinoma progression. Gastric Cancer. 22:705–722.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta stone of a hidden RNA
language. Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen Y, Li C, Pan Y, Han S, Feng B, Gao Y,
Chen J, Zhang K, Wang R and Chen L: The emerging role and promise
of long non coding RNAs in lung cancer treatment. Cell Physiol
Biochem. 38:2194–2206. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao Y, Wang ZQ, Tong J and Zheng Y: LncRNA
loc285194 inhibits tumor growth of laryngeal squamous cell
carcinoma cells by downregulating hexokinase 2. Exp Ther Med.
18:2378–2384. 2019.PubMed/NCBI
|
|
21
|
Meng W, Cui W, Zhao L, Chi W, Cao H and
Wang B: Aberrant methylation and downregulation of ZNF667-AS1 and
ZNF667 promote the malignant progression of laryngeal squamous cell
carcinoma. J Biomed Sci. 26:132019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M and Bozzoni I: A long non-coding
RNA controls muscle differentiation by functioning as a competing
endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sumazin P, Yang X, Chiu HS, Chung WJ, Iyer
A, Llobet-Navas D and Califano A: An extensive microRNA-mediated
network of RNA-RNA interactions regulates established oncogenic
pathways in glioblastoma. Cell. 147:370–381. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu XC, Xiao Y, Zhou Y, Zhou Z and Yan WG:
lncRNA SNHG20 promotes prostate cancer migration and invasion via
targeting the miR-6516-5p/SCGB2A1 axis. Am J Transl Res.
11:5162–5169. 2019.PubMed/NCBI
|
|
26
|
Han Y, Wu N, Jiang M, Chu Y, Wang Z, Liu
H, Cao J, Liu H, Xu B and Xie X: Long non-coding RNA MYOSLID
functions as a competing endogenous RNA to regulate MCL-1
expression by sponging miR-29c-3p in gastric cancer. Cell Prolif.
52:e126782019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kaul A, Schuster E and Jennings BH: The
Groucho co-repressor is primarily recruited to local target sites
in active chromatin to attenuate transcription. PLoS Genet.
10:e10045952014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ramasamy S, Saez B, Mukhopadhyay S, Ding
D, Ahmed AM, Chen X, Pucci F, Yamin R, Wang J, Pittet MJ, et al:
Tle1 tumor suppressor negatively regulates inflammation in vivo and
modulates NF-κB inflammatory pathway. Proc Natl Acad Sci USA.
113:1871–1876. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Y, Dehni G, Purcell KJ, Sokolow J,
Carcangiu ML, Artavanis-Tsakonas S and Stifani S: Epithelial
expression and chromosomal location of human TLE genes:
Implications for notch signaling and neoplasia. Genomics. 31:58–64.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brunquell C, Biliran H, Jennings S,
Ireland SK, Chen R and Ruoslahti E: TLE1 is an anoikis regulator
and is downregulated by Bit1 in breast cancer cells. Mol Cancer
Res. 10:1482–1495. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee JH, Son MW, Kim KJ, Oh MH, Cho H, Lee
HJ, Jang SH and Lee MS: Prognostic and Clinicopathological
significance of transducer-like enhancer of split 1 expression in
gastric cancer. J Gastr Cancer. 16:21–27. 2016. View Article : Google Scholar
|
